Adare Pharma Solutions: Integrated End-To-End CDMO Solutions…From Start To Finish

Article

Adare Pharma Solutions is a global technology-driven CDMO providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with expertise in complex oral formulations. Our specialized technology platforms provide taste masking, controlled release, solubility enhancement, and patient-centric dosing solutions. With a proven history in drug delivery, Adare has developed and manufactures more than 45 products sold by customers worldwide.

Adaptdose White Paper

Adaptdose™ allows drug developers to quickly create custom oral delivery systems and reduce time to market by eliminating the need to reformulate after Phase I in many cases.

DOWNLOAD

Duragran White Paper

DuraGran® reduces the amount of excipients and/or process steps used to build beads or controlled release granules, and for higher concentration doses can spheronization and extrusion steps typically used.
DOWNLOAD

Adare Pharma Solutions Interactive Brochure

This interactive brochure allows you to click through and learn more about all of Adare Pharma Solutions' major service offerings, technology platforms, and global facilities.
DOWNLOAD

Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content
Logo of Merck KgA, Merck is a German multinational science and technology company. | Image Credit: © Robert - stock.adobe.com

China’s NMPA Approves Merck KGaA Treatment for Tenosynovial Giant Cell Tumor

Patrick Lavery
June 10th 2025
Article

NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 innovative drug for adult patients with TGCTs that require systemic treatment.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

Washington, DC, USA - June 24, 2022: The symbol of the U.S. Department of Health and Human Services is seen at the entrance to its headquarters in the Hubert H. Humphrey Building in Washington, DC | Image Credit: © Tada Images - stock.adobe.com.

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

Christopher Cole
June 10th 2025
Article

The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry and beyond.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Cellular Landscapes: Breathtaking Images Showcasing the Intricacies of Cells and Microorganisms | Image Credit: © mky44 - stock.adobe.com

Achieving Targeted Delivery with Nanoscale Systems

Cynthia A. Challener
June 9th 2025
Article

cold storage room with shelves stocked with boxes and containers. Cooling fans and a digital temperature control panel ensure precise climate conditions. refrigeration - storage shelves | Image Credit: © Grispb - stock.adobe.com

Tjoapack Announces Packaging, Cold Chain Expansions in US and Netherlands

Patrick Lavery
June 9th 2025
Article

Most of the company’s new additions, if not already online, will be scheduled for commissioning, validation, or qualification before the fourth quarter of 2025.